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Simple Summary: Notwithstanding extensive research into fertility problems in mares, pregnancy
rates have remained low mainly because of endometrial inflammation (endometritis). In the field
of equine research, endometrial explants have been used to carry out in vitro studies of the mare’s
endometrium. However, there has been no wide-ranging assessment of relative stability of this
model over time. The aim of this study was to perform an in-depth transcriptomic assessment
of endometrial explants over a culture period of 72 h and assess if they are representative of the
whole mare. Explants at 24 h demonstrated significant changes when compared to biopsies at 0 h
as expected. Even though gene expression changes were seen between 24 and 48 h of culture, prior
to this window changes were dominated by the effects of explanting and culture and subsequently,
transcription was generally compromised. Our results, therefore have defined the optimal period
when explants can be used to study equine endometritis and how the endometrium is modulated
during inflammation. It highlights the use of abattoir derived samples to understand the physiology
and pathophysiology of the equine endometrium, negating the need to collect repeated uterine
biopsies from living mares.
Abstract: Persistent mating-induced endometritis is a major cause of poor fertility rates in the
mare. Endometritis can be investigated using an ex vivo equine endometrial explant system which
measures uterine inflammation using prostaglandin F2α as a biomarker. however, this model has
yet to undergo a wide-ranging assessment through transcriptomics. In this study, we assessed the
transcriptomes of cultured endometrial explants and the optimal temporal window for their use.
Endometrium harvested immediately post-mortem from native pony mares (n = 8) were sampled (0 h)
and tissue explants were cultured for 24, 48 and 72 h. Tissues were stored in RNALater, total RNA
was extracted and sequenced. Differentially expressed genes (DEGs) were defined using DESeq2
(R/Bioconductor). Principal component analysis indicated that the greatest changes in expression
occurred in the first 24 h of culture when compared to autologous biopsies at 0 h. Fewer DEGs were
seen between 24 and 48 h of culture suggesting the system was more stable than during the first
24 h. No genes were differentially expressed between 48 and 72 h but the low number of background
gene expression suggested that explant viability was compromised after 48 h. ESR1, MMP9, PTGS2,
PMAIP1, TNF, GADD45B and SELE genes were used as biomarkers of endometrial function, cell
death and inflammation across tissue culture timepoints. STRING assessments of gene ontology
suggested that DEGs between 24 and 48 h were linked to inflammation, immune system, cellular
processes, environmental information processing and signal transduction, with an upregulation of
most biomarker genes at 24 h. Taken together our observations indicated that 24–48 h is the optimal
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temporal window when the explant model can be used, as explants restore microcirculation, perform
wound healing and tackle inflammation during this period. This key observation will facilitate the
appropriate use of this as a model for further research into the equine endometrium and potentially
the progression of mating-induced endometritis to persistent inflammation between 24 and 48 h.
Keywords: RNA-seq; endometritis; endometrium; equine; reproduction; explant; transcriptome;
gene expression; tissue culture
1. Introduction
Persistent uterine inflammation (endometritis) has been extensively investigated in
horses as it is the main cause of subfertility in mares and the third most important clinical
problem affecting adult horses according to equine practitioners in the USA [1,2]. However,
for many years pregnancy rates in broodmares have remained low, between 50% and 65%
per oestrous cycle, despite extensive research into fertility problems [3,4]. Nearly 23,000
Thoroughbred (TB) mares were sent to the stud in Great Britain and Northern Ireland in
2019, yet only 61% produced a live foal [5]. It has been reported that 15–40% of a normal
population of TB mares suffer from persistent endometritis, reducing pregnancy rates by
13% [6,7].
In the field of equine research, endometrial explants have been used to carry out
many in vitro studies of the mare’s endometrium [8–10]. Tissue culture of explants has
distinct advantages over isolated cell culture models. The technique saves time as cell
culture requires several days or weeks to reach confluence [11]. Utilizing intact explants is
particularly important. Most tissue explant models mechanically chop the tissue aiming
for better oxygenation and perfusion of nutrients, but the chopping process itself leads to
damage and disruption of tissue architecture [11]. By using intact explants, the extracellular
matrix (ECM) remains intact which helps to maintain normal cell differentiation and
functioning. Chopping will release damage-associated molecular patterns (DAMPS) which
are intracellular and extracellular molecules typically released by the ECM after cell death
and/or injury. DAMPS modulate the innate immune system, triggering inflammation even
under sterile conditions [12,13], distorting the observations obtained because chopping
heavily wounds the tissue. As a result, some ex vivo bovine studies have adopted an
intact biopsy endometrium model to better mimic the whole cow [11,14]. Therefore, the
present study used the equine endometrial explant culture proposed by Nash et al. [15],
but substituted the mechanical tissue chopping by harvesting intact explants using sterile
punch biopsies, as advocated by Borges et al. [11].
Harvesting endometrium from uteri collected at an abattoir negates the need to
perform repeated uterine biopsies from living mares. Further, the large surface area of
endometrium provided by each mare can be entirely harvested so that several different
inflammatory stimuli and/or treatments of various concentrations can be concurrently
studied, maximizing technical replication. An equine endometrial explant culture system
composed of epithelial cells, stromal cells and resident leukocytes has been previously
optimised. As with the whole animal, cultured explants respond to inflammatory stim-
uli by secreting markers of inflammation such as prostaglandin F2α (PGF2α) [10,15,16].
Schwinghamer and colleagues [17] studied equine endometrial explants in culture for
periods of 12, 24 and 48 h to investigate whether explants undergo significant changes
during culture. They suggested that as early as 12 h of culture explants undergo cellular
damage based on the increase of lactate dehydrogenase (LDH) activity, and at 48 h of
culture light microscopy showed that some degenerative changes take place in the luminal
epithelium and in the epithelium lining deeper endometrial glands. Nonetheless, there
has been no assessment of global gene expression changes to intact equine endometrial
explants during the culture period.
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The aim was to undertake a transcriptomic assessment of ex vivo endometrial explants
collected from native pony mares cultured over a period of 72 h. It assessed whether
explants were representative of the whole mare in the pre-breeding, non-inflammatory
state and established whether the transcriptome stabilizes once in culture. A temporal
window relevant to persistent mating-induced endometritis was established in the current
study, evidencing potential for using the endometrial explant tissue culture model for
wider endometrium studies in horses. Therefore, the present study facilitates and informs
the use of this model for a more in-depth study of equine endometritis to understand how
the endometrium is modulated during inflammation.
2. Materials and Methods
2.1. Animals and Sample Collection
Uteri were collected from a random selection of native pony mares presented for
euthanasia at a commercial abattoir for reasons unrelated to this study. Mares were slaugh-
tered by free bullet followed by exsanguination of the jugular vein. Management of the
animals, age or reproductive history were unknown. Corresponding blood samples were
collected immediately after death from the jugular vein and stored in a plain vacutainer
(367895, BD Vacutainer, Plymouth, UK). To estimate the stage of the oestrous cycle for each
mare at the time of the death, uteri and cervices were physically and visually assessed
as previously described by various authors [15,18,19]. Briefly, uteri and cervix were as-
sessed for colour, appearance and tone whilst ovaries were immersed in a bucket with
water and analysed using an ultrasound scanner for assessment of ovarian structures and
follicle measurements (Table S1). The stage of oestrous cycle was retrospectively confirmed
by measuring serum progesterone (P4) concentrations from the blood sample collected
from each mare. Mares at the follicular phase of the oestrous cycle (n = 8) were utilized
in this study to represent the stage of cycle that clinical endometritis is likely to occur.
At the abattoir, endometrial biopsies were collected from each uteri within two hours of
death, with the aid of a sterilized biopsy instrument (Equivet uterine biopsy forceps 62 cm,
141965, Kruuse, Guildford, UK), placed into RNALater (10437114, Fisher, Leicestershire,
UK) and kept at 4 ◦C for 24 h during which samples were transported to the laboratory.
After 24 h, RNALater was removed and tissues were stored at −80 ◦C until RNA extraction.
These biopsy tissues were considered to be “0 h” endometrial samples in RNA-sequencing
(RNA-seq) analysis. Uteri and blood samples were stored on ice and transported back to
the laboratory within 6 h of collection. At the laboratory, serum P4 concentration was mea-
sured by an enzyme-linked immunosorbent assay (ELISA) kit (EIA 1561, DRG Diagnostics,
Marburg, Germany) following the manufacturer’s instructions to confirm the phase of the
oestrous cycle for each animal at the time of death.
2.2. Endometrial Cytology, Histology and Tissue Culture
To verify that uteri used were not inflamed, samples intended for cytological analysis
were collected at the abattoir from each tract, using a sterile cytobrush (Cytobrush plus
GT, C0112, Coopersurgical, Trumbull, CT, USA). Cytobrushes were rolled onto plain mi-
croscope slides and these were immediately airdried and subsequently fixed and stained
with eosin and methylene blue (Shandon Kwik-Diff Kit, 9990700, ThermoFisher Scientific,
Loughborough, UK). Specimens were evaluated by recording the number of neutrophils
per high power field (hpf; 400×) across 10 fields [20,21]. Findings were classified as: normal
(0 to 2 neutrophils/hpf), moderate inflammation (2 to 5 neutrophils/hpf) or severe inflam-
mation (>5 neutrophils/hpf) [22–24]. Uteri showing moderate to severe inflammation were
discarded from the study.
After transportation back to the laboratory, a biopsy was sampled from the uterine
body and immediately placed in Bouin’s Fixative Fluid (10821910, Fisher, Leicestershire,
UK). After fixation, tissues were subjected to several changes of 70% ethanol until their yel-
low colour disappeared. Tissues were then sectioned and placed into histological cassettes
(U4635-1CS, Sigma Aldrich, Exeter, UK) and subjected to dehydration, clearing and infiltra-
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tion. Sections of 8 µm were cut using a microtome (Minot 1212 rotary microtome, Ernst
Leitz GmbH, Wetzlar, Germany) and transferred onto a microscope slide (10149870, Fisher,
Leicestershire, UK) and placed on a hot plate at 40 ◦C to dry. Sections were de-waxed,
followed by rehydration in descending concentrations of ethanol and stained with Harris
haematoxylin and alcoholic 1% eosin for 5 min. Slides were mounted with Histomount
solution (008030, Invitrogen, Paisley, UK) and a coverslip. Slides were left to dry and
analysed under a light microscope. Histology slides were assessed by a Boarded Certified
Veterinary Pathologist following the Kenney classification system [25] to indicate patholog-
ical or degenerative endometrial changes. As a result of the histological assessment, mares
showing pathological or degenerative endometrial changes correspondent to category III
were discarded from tissue culture. The Kenney classifications for the mares used in this
study can be found in Table S2.
Working under aseptic conditions, punch biopsies were collected from the uterine
horns (8 mm Kai Biopsy punch, BP-80F, Northumbrian Medical Supplies, Newcastle Upon
Tyne, UK), immediately placed in warm supplemented Hank’s Buffered Saline Solution
(HBSS) (14175053, Fisher, Leicestershire, UK) and left in the incubator (5% CO2, 38 ◦C)
while biopsies from other uteri were harvested. Once biopsies were collected from all
uteri, the tissue culture was assembled in a laminar flow hood (Microflow Biological,
Bioquell, Andover, UK). Biopsy tissues were washed twice in un-supplemented HBSS and
cultured by placing individual biopsies into one well of a six-well culture plate (10578911,
Fisher, Leicestershire, UK). By following previously described protocols [11,15], biopsies
were placed at the bottom of the well or on top of a lens-tissue lined wire platform and
cultured in 3 mL and 4.25 mL of supplemented William’s Liquid E Medium (William’s
phenol red free, 500 mL, A12176-01, Fisher, Leicestershire, UK), respectively. Explant
cultures were performed in triplicate for each timepoint per animal. For all experiments,
tissue explants were incubated at 38 ◦C in 5% CO2 in air. After periods of 24, 48 and 72 h
explants were removed from the well and stored in 1.5 mL of RNALater for a 24 h period
at 4 ◦C. After 24 h in RNALater explants were removed and stored at −80 ◦C until RNA
extraction. William’s Liquid E Medium (500 mL) was supplemented with 0.01 µg/mL
epidermal growth factor (EGF) (10605-HNAE-250, Fisher, Leicestershire, UK), 0.1 mg/mL
neomycin (N6386, Sigma, Exeter, UK) and streptomycin (S6501, Sigma, Exeter, UK) solution,
2 mM of L-Glutamine (25030-032, ThermoFisher Scientific, Loughborough, UK), 2.5 µg/mL
amphotericin B (A2942-20ML, Sigma, Exeter, UK), 5 mL of insulin-transferrin-selenium
(ITS) (10524233, Fisher, Leicestershire, UK) and 50 mL of batch tested foetal bovine serum
(FBS) (Invitrogen FBS, 10695023, Fisher, Leicestershire, UK). The supplemented medium
was stored at 4 ◦C for a maximum period of 7 days. HBSS (100 mL), was supplemented
with 0.1 µg/mL EGF, 1 mL of 10 mg/mL neomycin and streptomycin solution, 2 mM of
L-Glutamine, 2.5 µg/mL Amphotericin B, 1 mL of ITS and 10 mL of FBS. Supplemented
HBSS was stored at 4 ◦C for a maximum of 2 days.
2.3. RNA Extraction, Quantification and Sequencing
Total RNA was extracted from endometrial samples using an RNA purification kit
(GeneJET RNA Purification Kit, Thermo Scientific, Bishops Stortford, UK) following the
manufacturer’s instructions. The NanoDrop 1000 Spectrophotometer (Thermo Scientific,
UK) was used to check RNA concentration and purity. In addition, RNA samples were frac-
tionated on a 1% agarose gel to assess RNA integrity which was indicated by visualization
of distinct 28S and 18S ribosomal RNA bands.
Complementary DNA (cDNA) synthesis, fragmentation and library preparation were
performed using the Illumina TruSeq Stranded mRNA kit (20020594, Illumina, San Diego,
CA, USA) according to the manufacturer’s instructions to prepare the dual-indexed next-
generation sequencing libraries. Briefly, from each sample poly-A messenger RNA (mRNA)
was purified, fragmented, and reversed transcribed into cDNA. The cDNA was end-
repaired and connected to adaptors that contained unique indexes for each sample. The
connected products were amplified by a polymerase chain reaction (PCR) (98 ◦C for 30 s,
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15 cycles of 98 ◦C for 10 s, 60 ◦C for 30 s, 72 ◦C for 30 s, 72 ◦C for 5 min and then cooling to
4 ◦C), followed by purification with AMPure (A63882, Beckman Coulter, High Wycombe,
UK) to remove PCR reagents and adaptor dimers. Product quantity in ng/µL was assessed
using a Qubit fluorescence spectrophotometer (Thermo Fisher Ltd.). The final library
dilution was 8 pM. The diluted library was loaded, bound, and amplified onto a flowcell
using an Illumina cBOT platform and then transferred to the HiSeq2500 and paired-end
sequencing runs in the 2 × 216 bp format.
2.4. Data Processing and Gene Expression Analysis
The pair-end sequencing produced forward and reverse reads for each sample, to-
talling 64 raw reads. Raw reads were subjected to quality analysis using FastQC software
(version 0.11.2) [26] and filtering using Trimmomatic software (version 0.33) [27] for se-
quencing adapters removal (i.e., ILLUMINACLIP), bases were removed from the beginning
and end of the reads if the quality was below 30 (i.e., LEADING or TRAILING = 30). A
sliding window trimming approach was performed once the average quality within the
window fell below 30 (i.e., SLIDINGWINDOW 4:30), reads were dropped if they were
below a specific length of 100 bp (i.e., MINLEN = 100), and a specified number of 10 bases
from the start of the read were removed (i.e., HEADCROP = 10). The quality of the trimmed
reads was assessed again by FastQC. Reads were mapped to the Equus caballus reference
genome (Ensembl, EquCab3.0; GCA_002863925.1) using Bowtie software (version 2.2.3) [28]
and TopHat software (version 2.0.14) [29]. The number of reads/fragments assigned to
genomic features for each sample and the Equus caballus annotation file available from
Ensembl website (version EquCab3.0) using the FeatureCounts software (version 1.5.2) [30].
Sequencing data are provided in Table S3. The concordant pair alignment rate to the
annotated equine genome from all samples was between 86.2% and 93.6%.
Differentially expressed genes (DEGs) were identified using the DESeq2 R/Bioconductor
version 1.28.1 [31,32]. Benjamini-Hochberg (BH) false discovery rate (FDR) method [33]
was performed in R (version 4.0.3) to correct for multiple testing. Genes were considered
differentially expressed at an FDR of 0.05 with a Log2 fold change (Log2FC) greater or
equal to ± 2. DEGs were submitted to the Search Tool for the Retrieval of Interacting
Genes/Proteins (STRING) database [34] (http://string-db.org, accessed on 5 February
2021) for network analysis and gene associations. Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathways [35] (http://www.genome.jp/kegg, accessed on 9 February
2021) were also used to identify significantly enriched pathways. Principal component
analyses (PCA) and heatmaps were generated using R (version 4.0.3).
3. Results
The global gene expression of equine endometrial explants (n = 8 horses) cultured
in vitro for periods of 24, 48 and 72 h were compared to autologous ex vivo 0 h biopsies,
representing the whole mare. Patters of gene expression were indicated by PCA based on
all gene expression, not solely DEGs (Figure 1). Samples obtained at 0 h were separated
from all others across the major source of variation along PC1. There was lesser variation
along PC2 with the samples with the 24 h samples being discrete from the 48 and 72 h
group which could not be distinguished.
To identify the sources of variation, DEG analyses were undertaken, comparing be-
tween time points. When comparing the transcriptomes of explants cultured for 24 h to
those of whole mares’ controls (0 h), 707 genes were significantly differentially upregu-
lated and 859 downregulated. In contrast, when comparing explant tissues cultured for
48 h relative to 24 h, only 53 genes were significantly upregulated while 27 genes were
downregulated. Finally, the transcriptome of explants cultured for 72 h revealed no dif-
ferentially expressed genes compared to 48 h samples. Table 1 compares the number of
expressed genes (background genes) and the number of DEGs between timepoints, whilst
Figures 2 and 3 graphically represent data featured in Table 1. It should be noted that
unlike the 0–48 h period relatively few genes were expressed within the 48–72 h window.
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Figure 1. PCA plot of the gene expression profiles for the eight horses. Biopsies taken at 0 h and 
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h time points). The paler ellipses represent 95 % confidence intervals for each experimental class. 
To identify the sources of variation, DEG analyses were undertaken, comparing be-
tween time points. When comparing the transcriptomes of explants cultured for 24 h to 
those of whole mares’ controls (0 h), 707 genes were significantly differentially upregu-
lated and 859 downregulated. In contrast, when comparing explant tissues cultured for 
48 h relative to 24 h, only 53 genes were significantly upregulated while 27 genes were 
downregulated. Finally, the transcriptome of explants cultured for 72 h revealed no dif-
ferentially expressed genes compared to 48 h samples. Table 1 compares the number of 
expressed genes (background genes) and the number of DEGs between timepoints, whilst 
Figures 2 and 3 graphically represent data featured in Table 1. It should be noted that 
unlike the 0–48 h period relatively few genes were expressed within the 48–72 h window. 
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Figure 2. Comparison of all genes expressed at all time points. Pairwise comparison of the number 
of genes expressed at the different time points (0, 24, 48 and 72 h) after mapping RNA-sequencing 
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Figure 3. Comparison of differentially expressed genes at all time points. Comparison of up and downregulated genes 
between all-time points (p < 0.05; Log2FC ≥ ± 2). * The comparison between 48 and 72 h of culture did not retrieve any DEG. 
Following the STRING functional enrichment analysis of DEGs between 0 and 24 h, 
a total of 41 KEGG pathways were found to be significantly enriched (Table S4). Table 2 
features KEGG pathways that are relevant to the current study. These indicated promi-
nent changes linked to inflammation, immune system, cellular processes, environmental 
information processing and signal transduction. STRING enrichment analysis of DEG be-
tween 24 and 48 h retrieved a total of five significantly enriched KEGG pathways (Table 
3). These suggested cell cycle events, cellular processes, and ECM remodelling. 
Table 2. The seven most important KEGG pathways when comparing the transcriptome at 24 h 
relative to the transcriptome at 0 h. Table created using the STRING website. 
Pathway Code a Description b Count c FDR p-Value d 
4610 Complement and coagulation cascades 27 1.27 × 10−09 
4512 ECM-receptor interaction 27 3.74 × 10−07 
4066 HIF-1 signaling pathway 29 5.20 × 10−07 
4060 Cytokine-cytokine receptor interaction 43 7.61 × 10−07 
4151 PI3K-Akt signaling pathway 55 2.48 × 10−05 
4510 Focal adhesion 39 1.58 × 10−04 
4668 TNF signaling pathway 22 2.12 ×10−03 
a KEGG pathway identification code. b Description of each KEGG pathway. c The number of genes 
involved in each pathway. d Overrepresented p-value with false discovery rate (FDR) statistical 
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reads to the equine reference genome.
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Figure 3. Comp rison of differentially express d genes at all time points. Comparison of up and
downregulated genes between all-ti e points (p < 0.05; Log2FC ≥ ± 2). * The compa ison between
48 and 72 h of culture did not retrieve any DEG.
Following the STRING functional enrichment analysis of DEGs betwe n 0 and 24 h,
a total of 41 KEGG pathways were found to be significantly enriched (Table S4). Table 2
features KEGG pathways that are relevant to the current study. These indicated prominent
changes linked to inflammation, immune system, cellular processes, environmental infor-
mation processing and signal transduction. STRING enrichment analysis of DE between
24 and 48 h retrieved a total of five significantly enriched KEGG pathways (Table 3). These
suggested cell cycle events, cellular processes, and ECM remodelling.
Table 2. The seven most important KEGG pathways when comparing the transcriptome at 24 h relative to the transcriptome
at 0 h. Table created using the STRING website.
Pathway Code a Description b Count c FDR p-Value d
4610 Complement and coagulation cascades 27 1.27 × 10−9
4512 ECM-receptor interaction 27 3.74 × 10−7
4066 HIF-1 signaling pathway 29 5.20 × 10−7
4060 Cytokine-cytokine receptor interaction 43 7.61 × 10−7
4151 PI3K-Akt signaling pathway 55 2.48 × 10−5
4510 Foc l adhesion 39 1.58 × 10−4
4668 TNF signaling pathway 22 2.12 ×10−3
a KEGG pathway identification code. b Description of each KEGG pathway. c The number of genes involved in each pathway. d Overrepre-
sented p-value with false discovery rate (FDR) statistical correction for multiple comparisons.
Table 3. Summary of the five enriched KEGG pathways when comparing the transcriptome at 48 h relative to the
transcriptome at 24 h. Table created using the STRING website.
Pathway Code a Description b Count c FDR p-Value d
4110 Cell cycle 6 0.007
4114 Oocyte meiosis 5 0.016
4630 Jak-STAT signalling pathway 5 0.036
4512 ECM-receptor interaction 4 0.040
4914 Progesterone-mediated oocyte maturation 4 0.040
a KEGG pathway identification code. b Description of each KEGG pathway. c The number of genes involved in each pathway. d Overrepre-
sented p-value with false discovery rate (FDR) statistical correction for multiple comparisons.
Genes previously used as biomarkers of endometrial function [17] were also stud-
ied to better understand explants’ functionality once in culture. The oestrogen recep-
tor, ESR1, was upregulated at 24 h vs. 0 h (FDR = 1.48 × 10−15; Log2FC = −2.5),
however it was not differentially expressed at 48 vs. 24 h (FDR = 0.35; Log2FC = 0.5).
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Whilst PTGS2, prostaglandin-endoperoxide synthase 2, was upregulated at 24 h vs. 0 h
(FDR = 1.97 × 10−27; Log2FC = 6), it was not differentially expressed at 48 h vs. 24 h of
culture (FDR = 0.99; Log2FC = −0.01). The possible initiation of cell death was considered
by examining the expression of GADD45B (growth arrest and DNA-damage-inducible
beta I) and PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1) [17]. GADD45B
was not differentially expressed at 24 h (FDR = 3.2 × 10−4; Log2FC = 1.6) nor at 48 h
(FDR = 0.35; Log2FC = −0.6) using the usual comparisons. PMAIP1 was upregulated at
24 h (FDR = 1.64 × 10−13; Log2FC = 3.1) but not differentially regulated at 48 h of culture
(FDR = 0.79; Log2FC = 0.2). Figure 4 displays a heatmap showing the expression pattern
(count matrix) of the biomarker genes: ESR1, MMP9, PTGS2, PMAIP1, TNF, GADD45B and
SELE. This indicted a transient increase in expression by most biomarkers at 24 h whilst
ESR1 was suppressed. At 48 and 72 h consistent elevated expression of MMP9, a matrix
metallopeptidase, was seen in each horse explant. Expression of PTGS2 (prostaglandin
processing gene) and PMAIP1 was induced at 24 h and maintained in each horse explant
up to 72 h. Correlation analyses indicated that ESR1 was inversely correlated with all
biomarker genes and most clearly with PTGS2 (Figure S1). In turn, PTGS2 was positively
correlated with all biomarker genes but ESR1.
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4. Discussion
Endometritis is a major cause of infertility in mares. Whilst endometritis has been
the subject of many studies that investigate pathophysiology, the development of a viable
explant model that maintains multicellular integrity would represent an important advance
to facilitate further study of the equine endometrium and better understand endometritis.
Preliminary approaches to develop such a model system have been proposed but these
lacked the extensive validation that is possible using transcriptomic approaches. In this
study, we describe distinctive phases of transcriptomic responses during explant culture.
In the present study, the upregulation of ESR1 at 24 h of culture implied that ex-
plants cultured for the first 24 h cannot be used to study oestrogen-responsive genes [17].
However, ESR1 is not differentially regulated at 48 h of culture, implying that explants
can indeed be used in the study of oestrogen responsiveness in the window of 24–48 h
of culture. Along with ESR1, PTGS2 was also used as a biomarker of endometrial func-
tion as it encodes an enzyme that plays a role in the conversion of arachidonic acid to
prostaglandin endoperoxide, which is an endometrial biomarker of inflammation [17,36].
PTGS2 upregulation at 24 h of culture indicates arachidonic acid processing, possibly
linked to inflammatory events during the first hours of culture due to explant removal from
uterus. Nonetheless, PTGS2 was not differentially regulated at 48 h of culture, possibly
Animals 2021, 11, 1995 9 of 14
indicating that at this time inflammation was stable. These findings might suggest that
this tissue model offers a short window of 24–48 h when further experiments which use
challenged explants to investigate endometritis-like events can be performed as suggested
by Schwinghamer et al. [17].
Growth arrest and DNA-damage-inducible beta I gene, GADD45B, that regulates
growth and apoptosis [37] was not regulated at 24 h nor at 48 h of culture. PMAIP1 (Phorbol-
12-Myristate-13-Acetate-Induced Protein 1) which encodes a pro-apoptotic protein [38]
was upregulated at 24 h of culture but it was not differentially regulated at 48 h. As
previously described by Schwinghamer et al. [17], both GADD45B and PMAIP1 can be
used as biomarkers of cellular death in equine endometrial explant systems. This implied
that cell death was triggered during the first 24 h of culture, but that apoptosis was not
likely to happen at 48 h. These observations also support relative stability in the explants
in the 24–48 h time frame. However, by 72 h only a very low number of genes were
expressed (804 at 72 h vs. 15290 at 48 h; Table 1) which aligns with Schwinghamer et al. [17]
observations that degenerative changes occur in cultured explants after 48 h of culture.
Thus, our transcriptomic experiments suggest a relatively short window of 24–48 h to
analyse endometrial tissue and to study endometritis using the explant system in the future.
During the initial 0–24 h culture phase there were a series of transcriptional changes
that were consistent with stress. The TNF signalling pathway, that plays a role in inflam-
matory cell proliferation, differentiation, survival and cell death [39], was upregulated at
24 h of culture (Figure S2). TNF induces the expression of E-selectin, SELE, that is involved
in the localization and development of inflammation [40,41]. The upregulation of SELE
is consistent with the upregulation of TNF-mediated inflammation during the first 24 h
of culture seen in the TNF signalling pathway. Increases in pro-inflammatory interleukin-
1β (IL–1β) and chemokine C-C motif ligand 20 (CCL20) also suggests that inflammation
was a feature of the explant system. Therefore, such observations are consistent with
inflammatory events being prominent in the explant culture during the first 24 h. The
upregulation of MMP9 should also be seen as wider change in the ECM that features in our
transcriptome during the first 24 h of culture. It is involved in the breakdown of ECM and
other normal physiological and pathological processes [42–44]. MMP9 has been linked to a
reduction in connective tissue deposition, in restoring microcirculation and it also plays
a role in wound repair [42,45,46]. The upregulation of MMP9 seen at 24 h suggests that
the explants have started healing wounds caused by mechanical removal from the uterus
and that they are trying to restore microcirculation to support their survival in the tissue
culture environment.
The ECM is a network of collagen, fibronectin, enzymes, proteoglycans and glyco-
proteins [47–49] that is continually remodelled to control tissue homeostasis, cell growth,
migration, differentiation and morphogenesis [50,51]. ECM molecules are then able to
control the magnitude of inflammation based on their ability to bind to different pattern
recognition receptors (PRRs). Equally, immune cells release enzymes and inflammatory me-
diators which can further degrade ECM or can alter its composition [52–54]. In our explant
system, most collagen coding genes were downregulated (COL17A1, COL21A1, COL2A1,
COL9A1, COL26A1, COL1A2, COL4A4 and COL4A6) and only two were upregulated
(COL12A1 and COL20A1) at 24 h. Type IX collagen plays an important role in the formation
of a collagen network and it maintains cartilage integrity and organization [55], which
might suggest that at 24 h of culture explants are building a collagen network to recover
from mechanical trauma. Downregulation of type IV collagen leads to an upregulation of
MMP9 and thus related to cell migration and invasion [56]. COL12A1 has been associated
with ligament ruptures in women [57], therefore its upregulation at 24 h of culture might
be related with tissue rupture after excision from the uterus. On the other hand, type XX
collagen is still not well understood and its function is relatively unknown [58].
An interplay between pro- and anti-inflammatory events is also suggested by exami-
nation of interleukin (IL) expression patterns in the cytokine–cytokine receptor interaction
pathway (Figure S3). Most ILs were found to be upregulated at 24 h of culture (IL1A, IL1B,
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IL1R2, IL1RN, IL21R, IL23A, IL24, IL2RA, IL31RA, IL36A, IL36G, IL4R and IL6) whilst IL25
(also known as IL17E) was the only IL shown to be downregulated. It has been shown that
during gut inflammation the production of IL25 protein is diminished [59]. This can sug-
gest that during the first 24 h of culture the explants are indeed undergoing inflammation,
thus the downregulation of IL25. The IL1 family group induces a network of proinflam-
matory cytokines, which regulate and initiate inflammatory responses [60]. IL24 belongs
to the IL10 family, and is released by immune cells such as monocytes, macrophages and
T cells [61]. IL24 is suggested to control cell proliferation and survival and it participates
in wound healing [62]. IL23A is a protein encoded by IL23 that plays an important role
in inflammatory responses. It also increases angiogenesis and upregulates MMP9 [63] as
seen in this explant tissue model. Most ILs found to be upregulated at 24 h of culture were
from the IL1 family, demonstrating that inflammation was a feature of explants during the
first hours of culture. CCR7, C-C motif chemokine receptor 7, was upregulated at 24 h of
culture and the C-C chemokine ligand family (CCLs) were differentially expressed. CCL2,
CCL11, CCL20, CCL26 and CCL27 were all upregulated whilst CCL24 was downregulated.
During physiological and pathological conditions, specially during inflammation, CCLs
play an important role in the recruitment of immune cells [64]. CCL24 is also involved in
pathological processes such as inflammation and fibrosis, but it has been found that CCL24
blockade can be used therapeutically to inhibit cell activation and pulmonary inflamma-
tion [65]. Therefore at 24 h there could be a recruitment of immune cells due to the local
inflammation produced after explant removal from uteri by CCLs. These events should be
considered as part of a modulatory event influencing explant cell growth in culture.
When comparing the transcriptome at 48 to the 24 h, IL23A and IL24 were downregu-
lated whilst CSF3R was upregulated in the cytokine–cytokine receptor interaction pathway.
CSF3R, colony-stimulating factor 3 receptor, is involved in the production, differentiation
and function of granulocytes and it also plays a role in cellular processes such as surface
adhesion and recognition [66,67]. A downregulation of interleukin-coding genes leads to
the hypothesis that the inflammatory process due to tissue injury was mounted, tackled
and it was returning to normal by 48 h of culture. At this stage the only TNF signalling
pathway output that was modulated was MMP9. As outlined, MMP9 is a pro-angiogenic
factor that is involved in ECM remodelling and that coordinates epithelial wound repair by
removing fibrinogen matrix and stimulating collagen contraction [42,46]. Therefore, wound
repair is still likely to be a feature of explants at 48 h. At 48 h of culture collagen (COL1A2
and COL24A1) and fibronectin (FN1) genes were also upregulated when compared to the
transcriptome of explants cultured for 24 h. Fibronectin binds cells with collagen fibres and
cell-surface integrins and is involved in cell adhesion, growth, migration, differentiation,
and other processes such as wound healing [68]. As fibronectin expression is directly linked
to epithelial cell growth [69], it would implicate explant cell growth at 48 h of culture.
A limitation of this work was undoubtedly the lack of medical history for the animals
from which uteri were collected as these were sourced from a commercial abattoir. It was
important that uteri used did not have any inflammation at the time of collection that
may adversely affect the data. As such the uteri collected were from native pony mares to
represent a population that had not been intensively managed. These ponies were collected
for commercial purposes unrelated to our study, from semi-feral populations that were
rounded up from the mountains of South Wales, UK, in the days before being transported
to the abattoir. Unlike domestic horses being sent to the abattoir, these were not being
slaughtered due to old age, injury or illness, but were otherwise healthy individuals, less
likely to have underling inflammatory processes present at the time of death. However,
as these semi-feral populations receive minimal management or intervention, no medical
history was documented or available to this project. In terms of uterine health specifically,
we insured that uterine inflammation was not apparent at the time of tissue collection
using cytological and histological assessment of each uterus used. Any animal that had
evidence of inflammation using these techniques was retrospectively disregarded from
the study. The cytological and histological analyses conferred confidence that, without a
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detailed medical history, the uteri of these mares were not undergoing inflammation at the
time of tissue collection.
5. Conclusions
This study provides the first comprehensive in vitro assessment of the pre-breeding,
non-inflammatory-challenged, global gene expression analysis of cultured equine endome-
trial explants and autologous ex vivo biopsies. It highlights the utility of abattoir-derived
samples to understand the physiology of the equine uterus. The upregulation of inter-
leukins, ESR1, PTGS2, PMAIP1, SELE and TNF is indicative that explants were undergoing
stress and inflammatory events during the first 24 h of culture. Nonetheless, at 24 h
explants also showed an upregulation of MMP9, which suggests that explants were under-
going microcirculation restoration and wound healing after removal from the uterus. The
downregulation of interleukin-coding genes and an upregulation of MMP9 seen at 48 h
of culture suggests that inflammatory processes were mounted and tackled and that the
tissue was restoring homeostasis between 24 to 48 h of culture. GADD45B and PMAIP1
were not differentially expressed at 48 h of culture, indicating that cell death was not
occurring at a significant level at this time. At 72 h of culture only a limited number of
genes were expressed by the explants when compared to the other timepoints, suggesting
that degenerative changes take place in the tissue after 48 h of culture.
We suggest that cultured explants may be a suitable exemplar to further study the
equine endometrium with particular application for modelling equine mating-induced
endometritis progression to persistent inflammation between 24 and 48 h once in culture.
Following future validation at the protein level, the explant tissue culture model may be
used for wider studies applied to endometritis in the mare and potentially also in dogs and
pigs as well as for investigating conditions underlying the endometrium.
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